{"title":"Treatment options for smoking cessation","authors":"PharmD Thea Moore","doi":"10.1016/S1082-7579(96)00090-8","DOIUrl":null,"url":null,"abstract":"<div><p>Tobacco use is considered the number one avoidable cause of morbidity and mortality in the United States. Considering the impact of tobacco use on the public health and economy, smoking cessation is an important concern for society as a whole. Higher prevalence of cigarette smoking among patients with psychiatric disorders makes smoking cessation an especially important issue for psychiatrists. Nicotine replacement therapy is the only FDA approved treatment for smoking cessation. Nicotine replacement is available in the form of gum, transdermal systems, and nasal spray. With the knowledge of available nonpharmacologic and pharmacologic treatments, and with recognition of the potential effects of smoking cessation on diagnosis and treatment of psychiatric disorders, psychiatrists can appropriately manage patients who are attempting to abstain from cigarette smoking.</p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"2 1","pages":"Pages 11-16"},"PeriodicalIF":0.0000,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(96)00090-8","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Update for Psychiatrists","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1082757996000908","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Tobacco use is considered the number one avoidable cause of morbidity and mortality in the United States. Considering the impact of tobacco use on the public health and economy, smoking cessation is an important concern for society as a whole. Higher prevalence of cigarette smoking among patients with psychiatric disorders makes smoking cessation an especially important issue for psychiatrists. Nicotine replacement therapy is the only FDA approved treatment for smoking cessation. Nicotine replacement is available in the form of gum, transdermal systems, and nasal spray. With the knowledge of available nonpharmacologic and pharmacologic treatments, and with recognition of the potential effects of smoking cessation on diagnosis and treatment of psychiatric disorders, psychiatrists can appropriately manage patients who are attempting to abstain from cigarette smoking.